HTA announces licence fees for 2022/23

Today the Human Tissue Authority (HTA) has published licence fee levels for the 2022/23 business year. 

 

Having held license fees at 2020/21 levels for the current business year the HTA Board have approved an increase of 2% on the current fee levels.  This increase will take effect from 1 April 2022 on the previous year’s fees. Read the full sector breakdowns.

Background to HTA licence fees

After taking account of all other income sources, we are required to generate in excess of £4m in income from licence fees in 2022/23.

In line with previous years of making efficiencies, holding budgets steady and absorbing new work, we have limited the increase to fees to cover the cost inflation pressures anticipated in the next financial year. 

Changes to this year’s fees

There is one new fee for the 2022/23 financial year as follows:

• new fee for import.

 

The 2022/23 fees have been increased by 2%, which is still below the annual Consumer Price Index rate of inflation published by the Office for National Statistics in September 2021, when the revised fees were proposed.  

Future years

This year we did not undertake a detailed fees review; however, we are mindful that our operating landscape is changing, which affects our licensing and regulatory processes as well as the establishments across all sectors. Over the next year a further review of our fees and structure will be conducted and we will ensure we engage with our stakeholders including consulting those affected by any significant changes.

If you have any questions regarding HTA licence fees, please email finance@hta.gov.uk.